The OmniPod Insulin Management System: the latest innovation in insulin pump therapy
Open Access
- 1 August 2010
- journal article
- review article
- Published by Springer Science and Business Media LLC in Diabetes Therapy
- Vol. 1 (1), 10-24
- https://doi.org/10.1007/s13300-010-0004-6
Abstract
This review of insulin pump therapy focuses on the OmniPod® Insulin Management System (Insulet Corp., Bedford, MA, USA). The OmniPod System is the first commercially available “patch pump.” It is a fully integrated wearable pump, controlled wirelessly through a handheld device containing a built-in blood glucose meter. This is an evaluation of the OmniPod System, with the aim of providing an educational tool for physicians who are considering recommending this product to their patients. The review includes a discussion of the traditional insulin pump configuration and its limitations, a detailed overview of the OmniPod System, references to clinical study data, planned product enhancements, its use as an insulin delivery system in the Juvenile Diabetes Research Foundation’s Artificial Pancreas Project, and its use to deliver additional compounds.This publication has 8 references indexed in Scilit:
- A Prospective Trial of U500 Insulin Delivered by Omnipod in Patients With Type 2 Diabetes Mellitus and Severe Insulin ResistanceEndocrine Practice, 2010
- Computer-Aided Learning in Insulin Pump TrainingJournal of Diabetes Science and Technology, 2010
- Siphon Effects on Continuous Subcutaneous Insulin Infusion Pump Delivery PerformanceJournal of Diabetes Science and Technology, 2010
- Closed-Loop Artificial Pancreas Using Subcutaneous Glucose Sensing and Insulin Delivery and a Model Predictive Control Algorithm: Preliminary Studies in Padova and MontpellierJournal of Diabetes Science and Technology, 2009
- Closed-Loop Artificial Pancreas Using Subcutaneous Glucose Sensing and Insulin Delivery and a Model Predictive Control Algorithm: The Virginia ExperienceJournal of Diabetes Science and Technology, 2009
- In Silico Evaluation Platform for Artificial Pancreatic β-Cell Development—A Dynamic Simulator for Closed-Loop Control with Hardware-in-the-LoopDiabetes Technology & Therapeutics, 2009
- Quantifying the Impact of a Short-Interval Interruption of Insulin-Pump Infusion Sets on Glycemic ExcursionsDiabetes Care, 2008
- OmniPod Insulin Management SystemDiabetes Care, 2006